Stockreport

Supernus reports Phase 2a data for SPN-820, stock climbs 6% [Seeking Alpha]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF from a Phase 2a study of its drug SPN-820 for the treatment of major depressive disorder in adults. Supernus ( SUPN ) said it expects to complete enrollment in a Phase [Read more]